Revenue
attach_money317M USD
YoY +84.6%
EGRXEagle Pharmaceuticals, Inc.$ --
Eagle Pharmaceuticals, Inc.
EGRX
$ -
-
You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.
analyticsIncome Statement Summary
FY2022 Full YearUpdated: 12/31/2022
Operating Income
bar_chart81M USD
YoY +2823.8%
Net Income
verified36M USD
YoY +513.1%
EPS
pie_chart2.76USD
YoY +518.2%
Quarterly Performance
Quarterly revenue and net income trend
RevenueOperating IncomeNet Income
No quarterly data available
Full-Year Progress
Full-year forecast not available
Income Statement Details
Item
Revenue
Cost of revenue
Gross profit
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
Interest expense
Income before tax
Income tax expense
Net income
Unlock Long-Term Income Statement Data
Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.